Inventages Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 4

Professionals

  • Investments
  • 64

  • Portfolio
  • 4

  • Exits
  • 43

Exits

Inventages General Information

Description

Founded in 2000, Inventages is the venture capital arm of Nestlé and is based in Nassau, Bahamas. The firm seeks to invest in early-stage companies operating in the life sciences, nutrition, and wellness sectors.

Contact Information

Website
www.inventages.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Corporate Venture Capital
Primary Office
  • Caves Village, West Bay Street Building Number 5
  • Office Number 4
  • Nassau, 7532
  • Bahamas
+1 (242) 000-0000

Inventages Investments (64)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Cerecin 05-Oct-2018 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 2 00000000 0000000000000
Biosys Health 01-Jan-2017 00000 00000 Biotechnology Out of Business 0000000 0000000
XO (Metal Containers & Packaging) 11-Jan-2016 00000 00000 000.00 Metal Containers and Packaging Generating Revenue 00000 000000
Cognoptix 29-Sep-2014 00000 00000 000.00 Diagnostic Equipment Generating Revenue 000000 0000000 00.0
AM-Pharma 10-Sep-2014 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3 00000 0000000000
Everlast Sports Nutrition 01-Oct-2013 00000 00000 Beverages Generating Revenue
Velle 01-Oct-2013 00000 00000 Food Products Generating Revenue
Phagenesis 22-May-2013 00000 00000 00.000 Therapeutic Devices Generating Revenue 00000 0000000000
ImmBio 18-Oct-2012 Later Stage VC 00.000 Drug Discovery Clinical Trials - Phase 1 00000 0000000000
GC-Rise 08-Oct-2012 Early Stage VC Other Healthcare Services Out of Business
You’re viewing 10 of 64 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Inventages Exits (43)

Company Name Exit Date Exit Type Exit Size
MSI Methylation Sciences 01-Nov-2022 Out of Business
Velle 01-Aug-2022 000000000 00000000
XO (Metal Containers & Packaging) 01-Aug-2022 000000000000000000
SelectX Pharmaceuticals 01-Mar-2022 000000000 00000000
Biosys Health 05-Jan-2021 000 00 00000000
Returnity 01-Jun-2020 000 00 00000000
GC-Rise 01-Feb-2020 000 00 00000000
Vital Foods 01-Feb-2020 000 00 00000000
Opsona Therapeutics 13-Jan-2019 Bankruptcy: Liquidation
Atonomics 01-Oct-2017 Out of Business
You’re viewing 10 of 43 exits. Get the full list »

Inventages Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Inventages Team (33)

Name Title Deals Funds Boards Office
Gunnar Weikert Ph.D Founder, Chairman & Chief Executive Officer 0 0 0 London, United Kingdom
Thomas Bayerl Ph.D Venture Partner Nassau, Bahamas
Wolfgang Reichenberger Partner 0 0 0 Nassau, Bahamas
Ashok Dhanrajgir Senior Vice President 0 0 0 Nassau, Bahamas
Kees Lucas Ph.D Venture Partner 0 London, United Kingdom
You’re viewing 5 of 33 team members. Get the full list »